Apidra

Active Ingredient(s): Insulin Glulisine Recombinant
FDA Approved: * April 16, 2004
Pharm Company: * SANOFI AVENTIS US
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Apidra Overview

Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir. It is an insulin analogue in which a fatty acid (myristic acid) is bound to the lysine amino acid at position B29. It is quickly absorbed after which it binds to albumin in the blood through its fatty acid at position B29. It then slowly dissociates from this complex. In a clinical study[1] that compared the efficacy and safe...

Read more Apidra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_detemir

Recent Apidra Forums: RSS Feed

Diffrences Of Insulins

Imean rapid insulin n long effect one, Apidra, aspart,n the grey colour pen insulins? ## Well, you've already specified the differences. There are some that work fast to bring your blood sugar down, which means they also don't work that long in the body, so they usually require more frequent dosing or must be followed by one of the other ones. The long acting are exactly that, they last longer in the body to help control your blood sugar for a longer period of time. The problem with them, however, is that they can take a bit to start working, so someone's sugar may rise for awhile, before it starts to bring them down. That's why they're often combined with a short acting. Learn more Insulin details here. Are you diabetic and using insulin?

Updated

Possible Dosages for this and Related Drugs:

Insulin Glulisine Recombinant
  • Injection: 0, 100 units/ml, 1000 units/10ml (100 units/ml), 300 units/3ml, 300 units/3ml (100 units/ml)
  • Powder: 1mg/inh, 3mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Apidra: (1 result)

Sorted by National Drug Code
  • 0088-2500 Apidra 100 [iu]/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC

Other drugs which contain Insulin Glulisine Recombinant or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA